Big and Little Forms of Osteoclast Activating Factor
Open Access
- 1 July 1977
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 60 (1) , 122-128
- https://doi.org/10.1172/jci108748
Abstract
We have further characterized osteoclast activating factor (OAF) using a bioassay for bone resorption which utilizes the release of previously incorporated 45Ca from fetal rat long bones in organ culture. When supernatant media from activated leukocyte cultures were concentrated on Amicon PM10 membranes (assigned molecular weight cutoff 10,000 daltons) and chromatographed on Sephadex G-50 columns, the bone-resorbing activity eluted between the molecular weight markers chymotrypsinogen (25,000 daltons) and cytochrome c (12,500 daltons). This peak of biological activity has been called big OAF. When filtrates from the PM10 membranes were concentrated on Amicon UM2 membranes (assigned molecular weight cutoff 1,000 daltons) and chromatographed on Sephadex G-50 columns, some of the biological activity eluted between the molecular weight markers chymotrypsinogen and cytochrome c (big OAF), but there was a separate peak of biological activity which eluted with [3H]proline (140 daltons). This second peak has been called little OAF. Little OAF was eluted from Bio-Gel P6 columns between the molecular weight markers calcitonin (approximately 3,500 daltons) and vitamin B12 (1,330 daltons), but was retained by Spectrapor dialysis tubing (nominal molecular weight cutoff 3,500 daltons). Big OAF was converted to little OAF by equilibration in 1 M NaCl or 2 M urea. Little OAF was self-associated back to big OAF by equilibration in buffers of low ionic strength (Tris-HCl 10-50 mM). Little OAF was extracted into the organic phase in ethyl acetate after acidification of the sample to pH 3.5. The biological activity remained in the aqueous phase after ethyl acetate extraction at pH 7.5-8.4. Little OAF has been purified more than 6,000-fold compared with the original material so that bone-resorbing activity is maximal in a sample with a protein concentration of 80 ng/ml.This publication has 15 references indexed in Scilit:
- Evidence for the Secretion of an Osteoclast Stimulating Factor in MyelomaNew England Journal of Medicine, 1974
- Partial Purification of Osteoclast-Activating Factor from Phytohemagglutinin-Stimulated Human LeukocytesJournal of Clinical Investigation, 1974
- Bone-Resorbing Activity in Supernatants from Lymphoid Cell LinesNew England Journal of Medicine, 1974
- Characterization of human migration inhibitory factor (MIF) from antigen-stimulated lymphocytesCellular Immunology, 1972
- Bone Resorbing Activity in Supernatant Fluid from Cultured Human Peripheral Blood LeukocytesScience, 1972
- Cellular hypersensitivity and immunity. Inhibition of macrophage migration and the lymphocyte mediators.1972
- Bone Resorption in Tissue Culture. Factors Influencing the Response to Parathyroid Hormone *Journal of Clinical Investigation, 1965
- Growth of embryonic avian and mammalian tibiae on a relatively simple chemically defined mediumExperimental Cell Research, 1961
- A SENSITIVE METHOD FOR THE ASSAY OF 5‐HYDROXYTRYPTAMINEBritish Journal of Pharmacology and Chemotherapy, 1957
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951